Retraction Note: MicroRNA-320a acts as a tumor suppressor by targeting BCR/ABL oncogene in chronic myeloid leukemia.
作者信息
Xishan Zhu, Ziying Lin, Jing Du, Gang Liu
机构信息
Clinical Research Center, Affiliated Hospital of Guangdong Medical College, Dongguang, 0086-027-7398722, China.
Department of Urology, Weifang Traditional Chinese Medicine Hospital, Weifang, 0086-0536-8300338, China.
出版信息
Sci Rep. 2023 Mar 2;13(1):3571. doi: 10.1038/s41598-023-30736-3.
Abstract
摘要
相似文献
1
Retraction Note: MicroRNA-320a acts as a tumor suppressor by targeting BCR/ABL oncogene in chronic myeloid leukemia.撤稿说明：微小RNA-320a通过靶向慢性髓性白血病中的BCR/ABL癌基因发挥肿瘤抑制作用。
Sci Rep. 2023 Mar 2;13(1):3571. doi: 10.1038/s41598-023-30736-3.
2
MicroRNA-320a acts as a tumor suppressor by targeting BCR/ABL oncogene in chronic myeloid leukemia.微小RNA-320a通过靶向慢性髓性白血病中的BCR/ABL癌基因发挥肿瘤抑制作用。
Sci Rep. 2015 Jul 31;5:12460. doi: 10.1038/srep12460.
3
[microRNA targeted to chronic myeloid leukemia Bcr-Abl oncogene screen using deacetylase inhibitor].[使用去乙酰化酶抑制剂针对慢性髓性白血病Bcr-Abl癌基因的微小RNA筛选]
Zhonghua Yi Xue Za Zhi. 2018 Jan 2;98(1):46-50. doi: 10.3760/cma.j.issn.0376-2491.2018.01.010.
4
miR-96 acts as a tumor suppressor via targeting the BCR-ABL1 oncogene in chronic myeloid leukemia blastic transformation.miR-96 通过靶向慢性髓系白血病原始细胞转化中的 BCR-ABL1 癌基因发挥肿瘤抑制作用。
Biomed Pharmacother. 2019 Nov;119:109413. doi: 10.1016/j.biopha.2019.109413. Epub 2019 Sep 10.
5
Deregulated expression of Cdc6 as BCR/ABL-dependent survival factor in chronic myeloid leukemia cells.在慢性髓性白血病细胞中，Cdc6作为BCR/ABL依赖性生存因子的表达失调。
Tumour Biol. 2017 Jun;39(6):1010428317713394. doi: 10.1177/1010428317713394.
6
BCR-ABL/GATA1/miR-138 mini circuitry contributes to the leukemogenesis of chronic myeloid leukemia.BCR-ABL/GATA1/miR-138 微型回路有助于慢性髓性白血病的白血病发生。
Oncogene. 2014 Jan 2;33(1):44-54. doi: 10.1038/onc.2012.557. Epub 2012 Dec 3.
7
Low-level expression of proapoptotic Bcl-2-interacting mediator in leukemic cells in patients with chronic myeloid leukemia: role of BCR/ABL, characterization of underlying signaling pathways, and reexpression by novel pharmacologic compounds.慢性髓性白血病患者白血病细胞中促凋亡Bcl-2相互作用介质的低水平表达：BCR/ABL的作用、潜在信号通路的特征以及新型药理化合物的重新表达
Cancer Res. 2005 Oct 15;65(20):9436-44. doi: 10.1158/0008-5472.CAN-05-0972.
8
Decreased microRNA-30a levels are associated with enhanced ABL1 and BCR-ABL1 expression in chronic myeloid leukemia.miR-30a 水平降低与慢性髓性白血病中 ABL1 和 BCR-ABL1 表达增强相关。
Leuk Res. 2013 Mar;37(3):349-56. doi: 10.1016/j.leukres.2012.12.003. Epub 2013 Jan 1.
9
The P190, P210, and P230 forms of the BCR/ABL oncogene induce a similar chronic myeloid leukemia-like syndrome in mice but have different lymphoid leukemogenic activity.BCR/ABL癌基因的P190、P210和P230形式在小鼠中诱导出类似慢性髓性白血病的综合征，但具有不同的淋巴细胞白血病致瘤活性。
J Exp Med. 1999 May 3;189(9):1399-412. doi: 10.1084/jem.189.9.1399.
本文引用的文献
1
PPM1D is a prognostic marker and therapeutic target in colorectal cancer.PPM1D是结直肠癌的一种预后标志物和治疗靶点。
Exp Ther Med. 2014 Aug;8(2):430-434. doi: 10.3892/etm.2014.1762. Epub 2014 Jun 6.
2
MicroRNA-338 inhibits growth, invasion and metastasis of gastric cancer by targeting NRP1 expression.微小RNA-338通过靶向神经毡蛋白1（NRP1）的表达来抑制胃癌的生长、侵袭和转移。
PLoS One. 2014 Apr 15;9(4):e94422. doi: 10.1371/journal.pone.0094422. eCollection 2014.
Zotero 插件